Symonds to join Novartis as deputy cfo in September

Published: 3-Jul-2009
Recruitment

Jonathan Symonds, currently managing director, Investment Banking, at Goldman Sachs will be joining Novartis on 1 September as deputy cfo and cfo designate, reporting to Raymund Breu, who will retire on 31 March, 2010, after 35 years of service to Novartis.

"Symonds\' financial expertise, broad industry experience and deep knowledge of the healthcare industry make him especially suited to take on the responsibilities of CFO," said Dr Daniel Vasella, chairman and ceo of Novartis.

Symonds spent eight years as cfo at AstraZeneca, where his position encompassed finance, M&A, strategy, IT, purchasing, business development and licencing. Before that he was finance director at Zeneca and a partner at KPMG.


Jonathan Symonds, currently managing director, Investment Banking, at Goldman Sachs will be joining Novartis on 1 September as deputy cfo and cfo designate, reporting to Raymund Breu, who will retire on 31 March, 2010, after 35 years of service to Novartis.

"Symonds' financial expertise, broad industry experience and deep knowledge of the healthcare industry make him especially suited to take on the responsibilities of CFO," said Dr Daniel Vasella, chairman and ceo of Novartis.

Symonds spent eight years as cfo at AstraZeneca, where his position encompassed finance, M&A, strategy, IT, purchasing, business development and licencing. Before that he was finance director at Zeneca and a partner at KPMG.

  • Companies:
  • Novartis
See more

You may also like

Recruitment

Novartis scoops Top Employer award

Read more
Novartis UK and its subsidiary, Sandoz, have been certified as ‘Top Employers’ of 2019 by Top Employers Institute

Trending Articles

  1. Siemens Industrial business appoints Finance Director
  2. Telesales Executive (Digital Media, Cosmetics & Pharma) HPCi Media – London, UK
  3. Retention, not just recruitment Six ways to protect your company from the skills crisis
  4. Yusen Logistics UK appoints new MD
  5. A cure for gender diversity stalling in pharma The cure for pharma to stop gender diversity stalling is to appoint more women in P&L roles finds The Pipeline report

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Recruitment

Novartis scoops Top Employer award

Novartis UK and its subsidiary, Sandoz, have been certified as ‘Top Employers’ of 2019 by Top Employers Institute
Recruitment

Rentschler Biopharma continues hiring at global sites

During 2021, the company has hired more than 300 employees across all business functions with a strong focus on production and laboratory personnel
Recruitment

Vetter Pharma invests $4.1m in Ravensburg training facility

The centre opened on September 14, with a small celebration held for management, training management and trainees.
Recruitment

Does pharma have a problem with inclusivity and innovation?

As we’ve seen only too clearly in recent weeks, the pharmaceutical industry is of paramount importance to the global economy and society. The collaboration regarding the COVID-19 pandemic is an example of the sector at its best, reports Stephen Frost, Founder, Frost Included
Recruitment

Cell Mogrify undergoes period of change

A cash injection and change in leadership gives momentum to the cell therapy company for direct cellular conversion platform
Recruitment

Retention, not just recruitment

Six ways to protect your company from the skills crisis
Recruitment

Particle Testing Authority (PTA) boosts company's thermal analysis capabilities

Particle Testing Authority (PTA), a division of Micromeritics Instrument Corporation, now has expanded thermal analysis capabilities with addition of Bryan Shaw to its team
Subscribe now